Davis Polk advised the representatives of the several underwriters in the offering.RxSight, Inc. executed an initial public offering of 7,350,000 shares of common stock at $16.00 per share….
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
